William Blair & Company’s Loxo Oncology, Inc LOXO Stock Holding History

William Blair & Company’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-3,290	Closed	-$461K	–	1762
2018 Q4	$461K	Buy	3,290 +771	+31%	+$117K	﹤0.01%	932
2018 Q3	$430K	Sell	2,519 -141	-5%	-$23.7K	﹤0.01%	1006
2018 Q2	$461K	Buy	+2,660	New	+$400K	﹤0.01%	976

Other funds holding LOXO

IUHSA

Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

William Blair & Company's LOXO Position: Q1 2019 in Review

William Blair & Company sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 3,290 shares — an estimated $461K sold.

William Blair & Company first reported a position in LOXO in Q2 2018 and held it in 3 quarters. The position peaked at $461K in Q4 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

William Blair & Company reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
William Blair & Company sold 3,290 Loxo Oncology, Inc shares in Q1 2019, an estimated $461K.
William Blair & Company first reported a position in Loxo Oncology, Inc in Q2 2018 and held it in 3 quarters.
William Blair & Company's Loxo Oncology, Inc position peaked at $461K in Q4 2018.
1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on William Blair & Company's 13F filing for Q1 2019, filed 14 May 2019.